ENVB Earnings

Quarterly EPS
$-43.10
Q3 2024
$-31.79
Q4 2024
$-14.58
Q1 2025
$-11.65
Q2 2025
$-10.81
Q3 2025
$-6.13
Q4 2025
$-1.08
Q1 2026
$-0.76
Q2 2026
Latest RevenueN/A
Latest Net Income-3027733
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.760-3027733—+93.5%
Q1 2026-$1.080-1633473—+92.6%
Q4 2025-$6.130-2194171—+80.7%
Q3 2025-$10.810-1873669—+74.9%
Q2 2025-$11.650-2519181—+73.9%
Q1 2025-$14.580-2184966—+86.8%
Q4 2024-$31.790-3154646—+88.3%
Q3 2024-$43.100-2084032—+81.6%
Q2 2024-$44.640-1894046——
Q1 2024-$110.520-2456915——
Q4 2023-$270.580-3435936——
Q3 2023-$234.000-2822216——
Enveric Biosciences (ENVB) — Earnings